Braslyn Ltd.
10% owner at Mirati Therapeutics, Inc.; 10% owner at INSG
- Sold, on record
- $99.6M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Mirati Therapeutics, Inc.10% owner
- INSGINSEEGO CORP.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- INSG2.4M shares
- Mirati Therapeutics, Inc.887,381 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.Plan not statedMar 1, 2019 2019
Sold 275,000 shares at $69.00 ($19M)
Braslyn Ltd., 10% owner
Sold 8.8% of holdings ($216M position)2.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJun 12, 2020 +469 days
Sold 600,000 shares at $69.00 ($41.4M)
Braslyn Ltd., 10% owner
Sold 19.1% of holdings ($216M position)2.5M shares leftFiling
- 3 Form 4 sale INSGPlan not statedDec 16, 2020 +187 days
Sold 2.4M shares at $15.44 ($36.8M)
Braslyn Ltd., 10% owner
Sold 23.9% of holdings ($154M position)7.6M shares leftFirst sale on recordFiling
- 4 Form 4 sale Mirati Therapeutics, Inc.Plan not statedMar 10, 2021 +84 days
Sold 12,381 shares at $197.64 ($2.4M)
Braslyn Ltd., 10% owner
Sold 0.4% of holdings ($622M position)3.1M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2021 | Mar 10, 2021 | Mirati Therapeutics, Inc. | 10% owner | Form 4 sale | 12,381 | $2.4M | 0.4% | Plan not stated | SEC |
| Dec 16, 2020 | Dec 16, 2020 | INSG | 10% owner | Form 4 sale | 2.4M | $36.8M | 23.9% | Plan not stated | SEC |
| Jun 12, 2020 | Jun 16, 2020 | Mirati Therapeutics, Inc. | 10% owner | Form 4 sale | 600,000 | $41.4M | 19.1% | Plan not stated | SEC |
| Mar 1, 2019 | Mar 5, 2019 | Mirati Therapeutics, Inc. | 10% owner | Form 4 sale | 275,000 | $19M | 8.8% | Plan not stated | SEC |